Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Shah, MR; Hasselblad, V; Stinnett, SS; Gheorghiade, M; Swedberg, K; Califf, RM; O'Connor, CM
   Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes
   JOURNAL OF CARDIAC FAILURE
   
   M.R. Shah et al., "Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes", J CARD FAIL, 7(2), 2001, pp. 105-113
2. Alexander, KP; Newby, LK; Hellkamp, AS; Harrington, RA; Peterson, ED; Kopecky, S; Langer, A; O'Gara, P; O'Connor, CM; Daly, RN; Califf, RM; Khan, S; Fuster, V
   Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   K.P. Alexander et al., "Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up", J AM COL C, 38(1), 2001, pp. 1-7
3. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P
   ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (vol 36, pg 970, 2000)
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   E. Braunwald et al., "ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (vol 36, pg 970, 2000)", J AM COL C, 38(1), 2001, pp. 294-295
4. Anderson, KM; Califf, RM; Stone, GW; Neumann, FJ; Montalescot, G; Miller, DP; Ferguson, JJ; Willerson, JT; Weisman, HF; Topol, EJ
   Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   K.M. Anderson et al., "Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention", J AM COL C, 37(8), 2001, pp. 2059-2065
5. Cantor, WJ; Hellkamp, AS; Peterson, ED; Zidar, JP; Cowper, PA; Sketch, MH; Tcheng, JE; Califf, RM; Ohman, EM
   Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   W.J. Cantor et al., "Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?", J AM COL C, 37(7), 2001, pp. 1883-1890
6. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselbad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
   Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001)
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   M.C. Bahit et al., "Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001)", J AM COL C, 37(7), 2001, pp. 2012-2012
7. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselblad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
   Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   M.C. Bahit et al., "Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb", J AM COL C, 37(4), 2001, pp. 1001-1007
8. Greenbaum, AB; Harrington, RA; Hudson, MP; MacAulay, CM; Wilcox, RG; Simoons, ML; Berdan, LG; Guerci, A; Cokkinos, DV; Kitt, MM; Lincoff, AM; Topol, EJ; Califf, RM; Ohman, EM
   Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   A.B. Greenbaum et al., "Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes", J AM COL C, 37(2), 2001, pp. 492-498
9. Roe, MT; Ohman, EM; Maas, ACP; Christenson, RH; Mahaffey, KW; Granger, CB; Harrington, RA; Califf, RM; Krucoff, MW
   Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   M.T. Roe et al., "Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion", J AM COL C, 37(1), 2001, pp. 9-18
10. DeLong, ER; Nelson, CL; Wong, JB; Pryor, DB; Peterson, ED; Lee, KL; Mark, DB; Califf, RM; Pauker, SG
    Using observational data to estimate prognosis: an example using a coronary artery disease registry
    STATISTICS IN MEDICINE
    
    E.R. DeLong et al., "Using observational data to estimate prognosis: an example using a coronary artery disease registry", STAT MED, 20(16), 2001, pp. 2505-2532
11. White, HD; Simes, RJ; Aylward, PEG; Armstrong, PW; Califf, RM; French, JK; Granger, CB; Marschner, IC; Topol, EJ; Van de Werf, FJ; Wilcox, RG
    Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
    LANCET
    
    H.D. White et al., "Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial", LANCET, 358(9296), 2001, pp. 1855-1863
12. Topol, EJ; Califf, RM; Van de Werf, F; Willerson, JT; Booth, J; White, H; Clayman, M; Deckelbaum, L; Lincoff, AM; Ohman, EM; Bates, E; Gibler, WB; Hochman, J; Kleiman, N; Grinfeld, L; Aylward, P; Armstrong, PW; Heikkila, J; Vahanian, A; Steg, G; Bode, C; Adgy, AAJ; Guetta, V; Ardissino, D; Savonitto, S; Bar, F; Simoons, M; Kontny, F; White, H; Sadowski, Z; Seabra-Gomes, R; Dalby, A; Betriu, A; Swahn, E; Wilcox, R; Frye, RL; Bertrand, ME; DeMets, D; Fox, KKA; Fuster, V; Lee, KL; McCarthy, C; Waller, M; Scherer, J; van de Kerkhove, A; Kukulewicz, L; Booth, JE; Del Valle, M; Hibert, D; Brannon, D
    Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial
    LANCET
    
    E.J. Topol et al., "Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial", LANCET, 357(9272), 2001, pp. 1905-1914
13. Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS
    Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
    LANCET
    
    H.D. Aronow et al., "Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study", LANCET, 357(9262), 2001, pp. 1063-1068
14. Akkerhuis, KM; Deckers, JW; Lincoff, AM; Tcheng, JE; Boersma, E; Anderson, K; Balog, C; Califf, RM; Topol, EJ; Simoons, ML
    Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    K.M. Akkerhuis et al., "Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention", J AM MED A, 286(1), 2001, pp. 78-82
15. Morse, MA; Califf, RM; Sugarman, J
    Monitoring and ensuring safety during clinical research
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    M.A. Morse et al., "Monitoring and ensuring safety during clinical research", J AM MED A, 285(9), 2001, pp. 1201-1205
16. Morse, MA; Califf, RM; Sugarman, J
    The role of local institutional review boards in protecting human researchsubjects - Reply
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    M.A. Morse et al., "The role of local institutional review boards in protecting human researchsubjects - Reply", J AM MED A, 285(21), 2001, pp. 2713-2713
17. Al-Khatib, SMN; Califf, RM; Hasselblad, V; Alexander, JH; McCrory, DC; Sugarman, J
    Short-term trials and long-term effects - Response
    SCIENCE
    
    S.M.N. Al-Khatib et al., "Short-term trials and long-term effects - Response", SCIENCE, 293(5539), 2001, pp. 2393-2394
18. Al-Khatib, SM; Califf, RM; Hasselblad, V; Alexander, JH; McCrory, DC; Sugarman, J
    Medicine - Placebo-controls in short-term clinical trials of hypertension
    SCIENCE
    
    S.M. Al-Khatib et al., "Medicine - Placebo-controls in short-term clinical trials of hypertension", SCIENCE, 292(5524), 2001, pp. 2013
19. Hudson, MP; Granger, CB; Topol, EJ; Pieper, KS; Armstrong, PW; Barbash, GI; Guerci, AD; Vahanian, A; Califf, RM; Ohman, EM
    Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials
    CIRCULATION
    
    M.P. Hudson et al., "Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials", CIRCULATION, 104(11), 2001, pp. 1229-1235
20. Barbash, GI; Birnbaum, Y; Bogaerts, K; Hudson, M; Lesaffre, E; Fu, YL; Goodman, S; Houbracken, K; Munsters, K; Granger, CB; Pieper, K; Califf, RM; Topol, EJ; Van de Werf, F
    Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies
    CIRCULATION
    
    G.I. Barbash et al., "Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies", CIRCULATION, 103(7), 2001, pp. 954-960
21. Newby, LK; Ohman, EM; Christenson, RH; Moliterno, DJ; Harrington, RA; White, HD; Armstrong, PW; Van de Werf, F; Pfisterer, M; Hasselblad, V; Califf, RM; Topol, EJ
    Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy
    CIRCULATION
    
    L.K. Newby et al., "Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy", CIRCULATION, 103(24), 2001, pp. 2891-2896
22. Jiang, W; Alexander, J; Christopher, E; Kuchibhatla, M; Gaulden, LH; Cuffe, MS; Blazing, MA; Davenport, C; Califf, RM; Krishnan, RR; O'Connor, CM
    Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure
    ARCHIVES OF INTERNAL MEDICINE
    
    W. Jiang et al., "Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure", ARCH IN MED, 161(15), 2001, pp. 1849-1856
23. Shah, MR; Hasselblad, V; Gheorghiade, M; Adams, KF; Swedberg, K; Califf, RM; O'Connor, CM
    Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy
    AMERICAN JOURNAL OF CARDIOLOGY
    
    M.R. Shah et al., "Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy", AM J CARD, 88(9), 2001, pp. 987-993
24. Birnbaum, Y; Goodman, S; Barr, A; Gates, KB; Barbash, GI; Battler, A; Barbagelata, A; Clemmensen, P; Sgarbossa, EB; Granger, CB; Califf, RM; Wagner, GS
    Comparison of primary coronary angioplasty versus thrombolysis in patientswith ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram
    AMERICAN JOURNAL OF CARDIOLOGY
    
    Y. Birnbaum et al., "Comparison of primary coronary angioplasty versus thrombolysis in patientswith ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram", AM J CARD, 88(8), 2001, pp. 842-847
25. O'Connor, CM; Gattis, WA; Hellkamp, AS; Langer, A; Larsen, RL; Harrington, RA; Berkowitz, SD; O'Gara, PT; Kopecky, SL; Gheorghiade, M; Daly, R; Califf, RM; Fuster, V
    Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)
    AMERICAN JOURNAL OF CARDIOLOGY
    
    C.M. O'Connor et al., "Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)", AM J CARD, 88(5), 2001, pp. 541-546
26. Tcheng, JE; Talley, JD; O'Shea, JC; Gilchrist, IC; Kleiman, NS; Grines, CL; Davidson, CJ; Lincoff, AM; Califf, RM; Jennings, LK; Kitt, MM; Lorenz, TJ
    Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study)
    AMERICAN JOURNAL OF CARDIOLOGY
    
    J.E. Tcheng et al., "Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study)", AM J CARD, 88(10), 2001, pp. 1097-1102
27. Al-Khatib, SM; Pieper, KS; Lee, KL; Mahaffey, KW; Hochman, JS; Pepine, CJ; Kopecky, SL; Akkerhuis, M; Stepinska, J; Simoons, ML; Topol, EJ; Califf, RM; Harrington, RA
    Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial
    AMERICAN JOURNAL OF CARDIOLOGY
    
    S.M. Al-Khatib et al., "Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial", AM J CARD, 88(1), 2001, pp. 76-79
28. Mast, ST; Gersing, KR; Anstrom, KJ; Krishnan, KR; Califf, RM; Jollis, JG
    Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation
    AMERICAN JOURNAL OF CARDIOLOGY
    
    S.T. Mast et al., "Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation", AM J CARD, 87(8), 2001, pp. 989-993
29. Peterson, JG; Topol, EJ; Roe, MT; Sapp, SK; Lincoff, AM; Deckers, JW; Blackstone, EH; Harrington, RA; Califf, RM; Lauer, MS
    Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes
    AMERICAN JOURNAL OF CARDIOLOGY
    
    J.G. Peterson et al., "Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes", AM J CARD, 87(5), 2001, pp. 532-536
30. Donahue, M; Fuster, V; Califf, RM
    Introduction: Cardiologists should target obesity
    AMERICAN HEART JOURNAL
    
    M. Donahue et al., "Introduction: Cardiologists should target obesity", AM HEART J, 142(6), 2001, pp. 1088-1090
31. Kandzari, DE; Lam, LC; Eisenstein, EL; Clapp-Channing, N; Fine, JT; Califf, RM; Mark, DB; Jollis, JG
    Advanced coronary artery disease: Appropriate end points for trials of novel therapies
    AMERICAN HEART JOURNAL
    
    D.E. Kandzari et al., "Advanced coronary artery disease: Appropriate end points for trials of novel therapies", AM HEART J, 142(5), 2001, pp. 843-851
32. Blazing, MA; de Lemos, JA; Dyke, CK; Califf, RM; Bilheimer, D; Braunwald, E
    The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy
    AMERICAN HEART JOURNAL
    
    M.A. Blazing et al., "The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy", AM HEART J, 142(2), 2001, pp. 211-217
33. Lundergan, CF; Ross, AM; McCarthy, WF; Reiner, JS; Boyle, D; Fink, C; Califf, RM; Topol, EJ; Simoons, ML; Van Den Brand, M; Van de Werf, F; Coyne, KS
    Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment potency, and body mass index - The GUSTO-I angiographic experience
    AMERICAN HEART JOURNAL
    
    C.F. Lundergan et al., "Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment potency, and body mass index - The GUSTO-I angiographic experience", AM HEART J, 142(1), 2001, pp. 43-50
34. Whellan, DJ; Shaw, LK; Bart, BA; Kraus, WE; Califf, RM; O'Connor, CM
    Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction
    AMERICAN HEART JOURNAL
    
    D.J. Whellan et al., "Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction", AM HEART J, 142(1), 2001, pp. 160-166
35. Shah, MR; Stinnett, SS; McNulty, SE; Gheorghiade, M; Zannad, F; Uretsky, B; Adams, KF; Califf, RM; O'Connor, CM
    Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST
    AMERICAN HEART JOURNAL
    
    M.R. Shah et al., "Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST", AM HEART J, 141(6), 2001, pp. 908-914
36. O'Shea, JC; Califf, RM
    Results of Expert Meetings: International differences in cardiovascular clinical trials - Barcelona, Spain - August 25-26, 1999 - Introduction
    AMERICAN HEART JOURNAL
    
    J.C. O'Shea e R.M. Califf, "Results of Expert Meetings: International differences in cardiovascular clinical trials - Barcelona, Spain - August 25-26, 1999 - Introduction", AM HEART J, 141(5), 2001, pp. 864-865
37. O'Shea, JC; Califf, RM
    International differences in cardiovascular clinical trials
    AMERICAN HEART JOURNAL
    
    J.C. O'Shea e R.M. Califf, "International differences in cardiovascular clinical trials", AM HEART J, 141(5), 2001, pp. 866-874
38. O'Shea, JC; Califf, RM
    International differences in treatment effects in cardiovascular clinical trials
    AMERICAN HEART JOURNAL
    
    J.C. O'Shea e R.M. Califf, "International differences in treatment effects in cardiovascular clinical trials", AM HEART J, 141(5), 2001, pp. 875-880
39. Shah, MR; O'Connor, CM; Sopko, G; Hasselblad, V; Califf, RM; Stevenson, LW
    Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale
    AMERICAN HEART JOURNAL
    
    M.R. Shah et al., "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale", AM HEART J, 141(4), 2001, pp. 528-535
40. Cohen, MG; Pacchiana, CM; Corbalan, R; Perez, JEI; Ponte, CI; Oropeza, ES; Diaz, R; Paolasso, E; Izasa, D; Rodas, MA; Urrutia, CE; Harrington, RA; Topol, EJ; Califf, RM
    Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial
    AMERICAN HEART JOURNAL
    
    M.G. Cohen et al., "Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial", AM HEART J, 141(3), 2001, pp. 391-401
41. Labinaz, M; Sketch, MH; Ellis, SG; Abramowitz, BM; Stebbins, AL; Pieper, KS; Holmes, DR; Califf, RM; Topol, EJ
    Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy
    AMERICAN HEART JOURNAL
    
    M. Labinaz et al., "Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy", AM HEART J, 141(3), 2001, pp. 469-477
42. Califf, RM; Ellenberg, SS
    Statistical approaches and policies for the operations of Data and Safety Monitoring Committees
    AMERICAN HEART JOURNAL
    
    R.M. Califf e S.S. Ellenberg, "Statistical approaches and policies for the operations of Data and Safety Monitoring Committees", AM HEART J, 141(2), 2001, pp. 301-305
43. Califf, RM; Lee, KL
    Data and safety monitoring committees: Philosophy and practice - Introduction
    AMERICAN HEART JOURNAL
    
    R.M. Califf e K.L. Lee, "Data and safety monitoring committees: Philosophy and practice - Introduction", AM HEART J, 141(1), 2001, pp. 154-155
44. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RMJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
    ACC/AHA guidelines for the management of patients with unstable angina andnon-ST segment elevation myocardial infarction: Executive summary and recommendations
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    E. Braunwald et al., "ACC/AHA guidelines for the management of patients with unstable angina andnon-ST segment elevation myocardial infarction: Executive summary and recommendations", CATHET C IN, 51(4), 2000, pp. 505-521
45. Califf, RM
    State of the art: ACS treatment at the turn of the century
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    R.M. Califf, "State of the art: ACS treatment at the turn of the century", EUR H J SUP, 2(F), 2000, pp. F2-F6
46. Eisenstein, EL; Peterson, ED; Jollis, JG; Tardiff, BE; Califf, RM; Knight, JD; Mark, DB
    Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome
    PHARMACOECONOMICS
    
    E.L. Eisenstein et al., "Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome", PHARMACOECO, 17(3), 2000, pp. 263-272
47. Kleiman, NS; Tracy, RP; Talley, JD; Sigmon, K; Joseph, D; Topol, EJ; Califf, RM; Kitt, M; Ohman, EM
    Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonistdoes not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    N.S. Kleiman et al., "Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonistdoes not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction", J THROMB TH, 9(1), 2000, pp. 5-12
48. Chang, WC; Fu, YL; Ohman, EM; Gupta, M; Morris, A; Roth, SN; Granger, CB; Califf, RM; Topol, EJ; Mark, DB; Armstrong, PW
    Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States
    CANADIAN JOURNAL OF CARDIOLOGY
    
    W.C. Chang et al., "Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States", CAN J CARD, 16(10), 2000, pp. 1231-1239
49. Auerbach, AD; Hamel, MB; Califf, RM; Davis, RB; Wenger, NS; Desbiens, N; Goldman, L; Vidaillet, H; Connors, AF; Lynn, J; Dawson, NV; Phillips, RS
    Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    A.D. Auerbach et al., "Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure", J AM COL C, 36(7), 2000, pp. 2119-2125
50. Herrmann, HC; Moliterno, DJ; Ohman, EM; Stebbins, AL; Bode, C; Betriu, A; Forycki, F; Miklin, JS; Bachinsky, WB; Lincoff, AM; Califf, RM; Topol, EJ
    Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    H.C. Herrmann et al., "Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial", J AM COL C, 36(5), 2000, pp. 1489-1496
51. Hasdai, D; Harrington, RA; Hochman, JS; Califf, RM; Battler, A; Box, JW; Simoons, ML; Deckers, J; Topol, EJ; Holmes, DR
    Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Hasdai et al., "Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation", J AM COL C, 36(3), 2000, pp. 685-692
52. Goodman, SG; Cohen, M; Bigonzi, F; Gurfinkel, EP; Radley, DR; Le Iouer, V; Fromell, GJ; Demers, C; Turpie, AGG; Califf, RM; Fox, KAA; Langer, A
    Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    S.G. Goodman et al., "Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study", J AM COL C, 36(3), 2000, pp. 693-698
53. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
    ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    E. Braunwald et al., "ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction", J AM COL C, 36(3), 2000, pp. 970-1056
54. Hasdai, D; Granger, CB; Srivatsa, SS; Criger, DA; Ellis, SG; Califf, RM; Topol, EJ; Holmes, DR
    Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000)
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Hasdai et al., "Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000)", J AM COL C, 36(2), 2000, pp. 660-660
55. Sane, DC; Damaraju, LV; Topol, EJ; Cabot, CF; Mascelli, MA; Harrington, RA; Simoons, ML; Califf, RM
    Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D.C. Sane et al., "Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy", J AM COL C, 36(1), 2000, pp. 75-83
56. Kleiman, NS; Califf, RM
    Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    N.S. Kleiman e R.M. Califf, "Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000", J AM COL C, 36(1), 2000, pp. 310-310
57. Hasdai, D; Granger, CB; Srivatsa, SS; Criger, DA; Ellis, SG; Califf, RM; Topol, EJ; Holmes, DR
    Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Hasdai et al., "Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy", J AM COL C, 35(6), 2000, pp. 1502-1512
58. Lincoff, AM; Califf, RM; Topol, EJ
    Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    A.M. Lincoff et al., "Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease", J AM COL C, 35(5), 2000, pp. 1103-1115
59. Alderman, EL; Brooks, MM; Bourassa, M; Califf, RM; Chaitman, BR; Detre, K; Faxon, D; Frye, R; Hardison, RM; Hlatky, M; Holubkov, R; Jones, RH; Kelsey, SF; Schaff, H; Shemin, RJ; Sopko, G; Sutton-Tyrrell, K; Williams, DO
    Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    E.L. Alderman et al., "Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status", J AM COL C, 35(5), 2000, pp. 1122-1129
60. Shah, A; Wagner, GS; Granger, CB; O'Connor, CM; Green, CL; Trollinger, KM; Califf, RM; Krucoff, MW
    Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    A. Shah et al., "Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment", J AM COL C, 35(3), 2000, pp. 666-672
61. Hasdai, D; Califf, RM; Thompson, TD; Hochman, JS; Ohman, EM; Pfisterer, M; Bates, ER; Vahanian, A; Armstrong, PW; Criger, DA; Topol, EJ; Holmes, DR
    Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Hasdai et al., "Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction", J AM COL C, 35(1), 2000, pp. 136-143
62. Akkerhuis, KM; Deckers, JW; Boersma, E; Harrington, RA; Stepinska, J; Mahaffey, KW; Wilcox, RG; Lincoff, AM; Keltai, M; Topol, EJ; Califf, RM; Simoons, ML
    Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT
    EUROPEAN HEART JOURNAL
    
    K.M. Akkerhuis et al., "Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT", EUR HEART J, 21(5), 2000, pp. 371-381
63. Menon, V; Hochman, JS; Stebbins, A; Pfisterer, M; Col, J; Anderson, RD; Hasdai, D; Holmes, DR; Bates, ER; Topol, EJ; Califf, RM; Ohman, EM
    Lack of progress in cardiogenic shock: lessons from the GUSTO trials
    EUROPEAN HEART JOURNAL
    
    V. Menon et al., "Lack of progress in cardiogenic shock: lessons from the GUSTO trials", EUR HEART J, 21(23), 2000, pp. 1928-1936
64. McGuire, DK; Emanuelsson, H; Granger, CB; Ohman, EM; Moliterno, DJ; White, HD; Ardissino, D; Box, JW; Califf, RM; Topol, EJ
    Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study
    EUROPEAN HEART JOURNAL
    
    D.K. McGuire et al., "Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study", EUR HEART J, 21(21), 2000, pp. 1750-1758
65. O'Shea, JC; Califf, RM
    Inter-regional differences in acute coronary syndrome trials
    EUROPEAN HEART JOURNAL
    
    J.C. O'Shea e R.M. Califf, "Inter-regional differences in acute coronary syndrome trials", EUR HEART J, 21(17), 2000, pp. 1397-1399
66. Dyke, CK; Califf, RM
    National and regional registries: what good are they?
    EUROPEAN HEART JOURNAL
    
    C.K. Dyke e R.M. Califf, "National and regional registries: what good are they?", EUR HEART J, 21(17), 2000, pp. 1401-1403
67. Tcheng, JE; O'Shea, JC; Cohen, EA; Pacchiana, CM; Kitt, MM; Lorenz, TJ; Greenberg, S; Strony, J; Califf, RM; Buller, C; Cantor, WJ; Joseph, DM; Kitt, MM; Lincoff, AM; Madan, M; Popma, J; Teirstein, P; Cohen, E; Balleza, L; Parsons, P; Lui, H; Young, J; Fox, R; Labinaz, M; Jelley, J; Williams, J; Cohen, D; Trovato, M; Smith, J; Henry, P; Chisholm, R; O'Donnell, D; Talley, JD; Pacheco, R; Timmis, S; Muraka, A; Mann, T; Cubeddu, G; Tannenbaum, M; Greene, J; Santoian, E; Wash, M; Sheldon, S; Pronesti, L; Jain, A; Alonzo, M; Seidelin, P; Richards, J; Lopez, M; Dittenber, R; Johnson, K; Levine, G; Maresh, K; Ferrando, T; Sarembock, I; Snyder, L; Kieval, J; Herlan, L; Miller, M; Bembridge, D; Nair, R; Hickel, L; Kiernan, F; Murphy, D; Cloutier, J; Conn, E; Beardsley, J; Ritchie, M; Cragen, D; Jafar, MZ; Counihan, P; Rosenfelder, D; Ducas, J; Montebruno, L; Carere, R; Radons, B; Williams, L; Owens, W; Dougal, R; Feldman, R; Audrain, D; Karamali, A; Smith, M; Blankenship, J; Demko, SL; Thompson, M; Gacoich, G; Chiodo, V; Noll, P; Ledley, G; Miller, C; Felten, W; Garner, B; Chandler, AB; Easler, P; Albin, G; Page, A; Maddox, W; Allen, S; Gilchrist, I; Moore, R; Zimmerman, H; Curtis, M; Hildebrand, K; Greene, R; Healy, E; Meengs, W; Carson, D; George, J; Roncevich, T; Aharonian, V; Browning, R; Kostuk, W; Carr, S; Feit, F; Gostomsky, B; Butman, S; Hannah, E; Hassel, CD; Hartley, D; Shook, T; Hiller-Mullin, S; Brill, D; Dillion, M; Armstrong, B; Kerns, D; Pichard, A; Okubagzi, P; Nasser, T; Driver, L; Garrett, J; Boltey, L; Stouffer, G; Potter, M; Amidon, T; Eggert, S; Taussig, A; Potter, K; Natarajan, M; Tartaglia, C; Werner, J; Dunlap, T; Harrold-Runge, P; Davidson, C; Goodreau, L; Herzog, W; Calamunci, N; Slater, A; Tormey, D; Phillips, W; White, D; Sridhar, K; White, J; Goodman, D; Buchbinder, M; Nasser, V; Rapeport, K; Vorman, P; Weiner, B; Borbone, M; Shadoff, N; Paap, C; Rehman, A; Haag, E; Burchenal, J; Kioussopoulos, K; Senior, D; Senior, J; Piana, R; Kirshenbaum, J; Chan, S; Chowdry, A; Kraft, P; Clark, V; Fox, M; Deutsch, E; Shannon, T; Quesada, R; Brotherton, J; Murrin, C; Cinderella, J; Hearne, S; Seefried, V; Farah, T; Pakstis, D; Bartolet, B; Bond, C; Debarardinis, C; Montory, D; Smith, G; Gray, D; Phillips, P; Hathaway, S; Manoukian, S; Patrick, C; Yakubov, S; Brooks, J; Block, P; Block, B; Muhlestein, JB; Kim, S; Shalev, Y; Schmidt, W; Resar, J; Citro, K; Stine, R; Zumbuhl, J; Moreyra, A; Kreiger, S; Berger, P; Cannon, CP; Fisher, L; Hasselblad, V; Foster, A; Joseph, D; Madan, M; McLendon, C; Rund, M; Tillery, N; Wood, F; Mahaffey, KW; Irwin, C; Kulick, D; Johnson, N; Chen, J; Greenberg, S; Hogeboom, C; Lorenz, TJ; Terifay, R; Strony, J; Veltri, E
    Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
    LANCET
    
    J.E. Tcheng et al., "Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial", LANCET, 356(9247), 2000, pp. 2037-2044
68. Newby, LK; Bhapkar, MV; Lee, KL; Califf, RM
    Randomisation in the SYMPHONY trial - Reply
    LANCET
    
    L.K. Newby et al., "Randomisation in the SYMPHONY trial - Reply", LANCET, 356(9240), 2000, pp. 1521-1522
69. Hasdai, D; Topol, EJ; Califf, RM; Berger, PB; Holmes, DR
    Cardiogenic shock complicating acute coronary syndromes
    LANCET
    
    D. Hasdai et al., "Cardiogenic shock complicating acute coronary syndromes", LANCET, 356(9231), 2000, pp. 749-756
70. Velazquez, EJ; Califf, RM
    All that glitters is not gold
    LANCET
    
    E.J. Velazquez e R.M. Califf, "All that glitters is not gold", LANCET, 355(9215), 2000, pp. 1568-1569
71. Topol, CE; Califf, RM; Simes, RJ; Van de Werf, F; Diaz, R; Paolasso, E; Aylward, PE; Keech, A; Klein, W; Piegas, L; Tomov, I; Armstrong, PW; Widimsky, P; Grande, P; Halinen, M; Vahanian, A; Neuhaus, K; Dimas, AP; Preda, I; Kristinsson, A; Tzivoni, D; Ardissino, D; White, HD; Madsen, S; Sugrue, D; Sadowski, Z; Seabra-Gomes, R; Apetrei, E; Dalby, A; Betriu, A; Pfisterer, M; Verheugt, F; Fox, K; Bates, ER; Gibler, WB; Granger, CB; Harrington, RA; Hochman, JS; Holmes, DR; Kleiman, NS; Lee, KL; Moliterno, DJ; Newby, LK; Ohman, EM; Califf, R; Newby, K; Zillman, L; Lee, K; Lemons, P; McCourt, B; Campbell, C; Tardiff, B; Snapp, J; Bassett, K; Hodgson, P; Hannan, K; Kandzari, L; Hawkins, S; Hinman-Smith, E; McDougal, M; Raffetto, K; Thompson, D; Wehrle, T; Ange, C; Brown, R; Grissom, G; Heuckel, M; McCall, J; Pennachi, W; Spychala, M; Veasey, S; Pullium, M; Journey, T; Quintero, K; Mark, D; Davidson-Ray, L; Diner, L; Nelson, C; Sowers, C; Webb, G; Young, M; Bhapkar, M; Pacchiana, C; Sparapani, R; Tuttle, R; Weaver, D; Borzak, S; Douthat, L; Topol, E; Moliterno, D; Konczos, L; Baishnab, R; Baishnab, R; Bakos, A; Blashford, L; Bratsch, J; Brown, K; Cadorini, E; Carlson, J; Clemmons, P; DelValle, M; Drabik, M; Fu, G; Gates, K; Gibson, Y; Heil, L; Hill, N; Klancar, R; McHale, B; Montague, E; Pasca, N; Pergi, L; Randall, R; Rosso, R; Sankovich, K; Smith, D; Wisniewski, L; Witkowski, M; Zovkic, V; Alexander, K; Bhatt, D; Brener, S; Campbell, L; Cho, L; Cole, C; Deedy, M; Foody, J; Gassler, J; Ghaffari, S; Haas, G; Kapadia, S; Lauer, M; Lauer, MS; Lincoff, M; Lutton, S; Marso, S; Mukherjee, D; Patel, V; Penn, M; Robbins, M; Roe, M; Sila, C; Thamilarasan, M; Wagner, G; Armstrong, P; Bestilny, S; Van de Werf, F; Budts, W; Graux, S; Luyten, A; Simes, J; Keech, A; Kava, M; Bower, T; Chan, S; Crampton, L; Monro, C; Nayak, M; Parente, G; Riley, V; Wilton, D; Aylward, P; Dolan, S; Thomas, C; White, H; Scott, M; Frye, R; Alpert, J; Bertrand, M; Ryan, T; Fisher, L; Asarch, L; Smith, M; Lim, L; Bokslag, M; Chiu, P; Chung, J; Collins, S; Dougherty, C; Guimaraes, D; Hakim, Z; Mathieson, J; Montgomery, L; Novotny, B; Steiner, B; Wittke, B
    Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
    LANCET
    
    C.E. Topol et al., "Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial", LANCET, 355(9201), 2000, pp. 337-345
72. Alexander, JH; Sparapani, RA; Mahaffey, KW; Deckers, JW; Newby, LK; Ohman, EM; Corbalan, R; Chierchia, SL; Boland, JB; Simoons, ML; Califf, RM; Topol, EJ; Harrington, RA
    Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    J.H. Alexander et al., "Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation", J AM MED A, 283(3), 2000, pp. 347-353
73. Califf, RM; O'Connor, CM
    beta-blocker therapy for heart failure - The evidence is in, now the work begins
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    R.M. Califf e C.M. O'Connor, "beta-blocker therapy for heart failure - The evidence is in, now the work begins", J AM MED A, 283(10), 2000, pp. 1335-1337
74. Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB
    Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    L.K. Newby et al., "Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction.", N ENG J MED, 342(11), 2000, pp. 749-755
75. Akkerhuis, KM; Maas, ACP; Klootwijk, PAJ; Krucoff, MW; Meij, S; Califf, RM; Simoons, ML
    Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction
    JOURNAL OF ELECTROCARDIOLOGY
    
    K.M. Akkerhuis et al., "Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction", J ELCARDIOL, 33(2), 2000, pp. 127-136
76. Harrington, RA; Armstrong, PW; Graffagnino, C; Van de Werf, F; Kereiakes, DJ; Sigmon, KN; Card, T; Joseph, DM; Samuels, R; Granett, J; Chan, R; Califf, RM; Topol, EJ
    Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease
    CIRCULATION
    
    R.A. Harrington et al., "Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease", CIRCULATION, 102(7), 2000, pp. 728-735
77. Berger, PB; Criger, DA; Holmes, DR; Ellis, SG; Granger, CB; Betriu, A; Topol, EJ; Califf, RM
    Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Response
    CIRCULATION
    
    P.B. Berger et al., "Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Response", CIRCULATION, 102(4), 2000, pp. E29-E30
78. Lincoff, AM; Mark, DB; Tcheng, JE; Califf, RM; Bala, MV; Anderson, KM; Davidson-Ray, L; Knight, JD; Cabot, CF; Topol, EJ
    Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization - Results from the EPILOG randomized trial
    CIRCULATION
    
    A.M. Lincoff et al., "Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization - Results from the EPILOG randomized trial", CIRCULATION, 102(24), 2000, pp. 2923-2929
79. Marso, SP; Bhatt, DL; Roe, MT; Houghtaling, PL; Labinaz, M; Kleiman, NS; Dyke, C; Simmoons, ML; Califf, RM; Harrington, RA; Topol, EJ
    Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting
    CIRCULATION
    
    S.P. Marso et al., "Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting", CIRCULATION, 102(24), 2000, pp. 2952-2958
80. Topol, EJ; Ohman, EM; Armstrong, PW; Wilcox, R; Skene, AM; Aylward, P; Simes, J; Dalby, A; Betriu, A; Bode, C; White, HD; Hochman, JS; Emanuelson, H; Vahanian, A; Sapp, S; Stebbins, A; Moliterno, DJ; Califf, RM
    Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) IIItrial
    CIRCULATION
    
    E.J. Topol et al., "Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) IIItrial", CIRCULATION, 102(15), 2000, pp. 1761-1765
81. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepin, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
    ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina) (vol 102, pg 1193, 2000)
    CIRCULATION
    
    E. Braunwald et al., "ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina) (vol 102, pg 1193, 2000)", CIRCULATION, 102(14), 2000, pp. 1739-1739
82. Califf, RM
    Cigarette smoking - How much worse can it get?
    CIRCULATION
    
    R.M. Califf, "Cigarette smoking - How much worse can it get?", CIRCULATION, 102(12), 2000, pp. 1340-1341
83. Fu, YL; Chang, WC; Mark, D; Califf, RM; Mackenzie, B; Granger, CB; Topol, EJ; Hlatky, M; Armstrong, PW
    Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial - One-year follow-up of patients without ST-segment elevation
    CIRCULATION
    
    Y.L. Fu et al., "Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial - One-year follow-up of patients without ST-segment elevation", CIRCULATION, 102(12), 2000, pp. 1375-1381
84. Lincoff, AM; Harrington, RA; Califf, RM; Hochman, JS; Guerci, AD; Ohman, EM; Pepine, CJ; Kopecky, SL; Kleiman, NS; Pacchiana, CM; Berdan, LG; Kitt, MM; Simoons, ML; Topol, EJ
    Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition - Insights from the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial
    CIRCULATION
    
    A.M. Lincoff et al., "Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition - Insights from the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial", CIRCULATION, 102(10), 2000, pp. 1093-1100
85. Roe, MT; Harrington, RA; Prosper, DM; Pieper, KS; Bhatt, DL; Lincoff, AM; Simoons, ML; Akkerhuis, M; Ohman, EM; Kitt, MM; Vahanian, A; Ruzyllo, W; Karsch, K; Califf, RM; Topol, EJ
    Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease
    CIRCULATION
    
    M.T. Roe et al., "Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease", CIRCULATION, 102(10), 2000, pp. 1101-1106
86. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
    ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina)
    CIRCULATION
    
    E. Braunwald et al., "ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina)", CIRCULATION, 102(10), 2000, pp. 1193-1209
87. Kleiman, NS; Lincoff, AM; Flaker, GC; Pieper, KS; Wilcox, RG; Berdan, LG; Lorenz, TJ; Cokkinos, DV; Simoons, ML; Boersma, E; Topol, EJ; Califf, RM; Harrington, RA
    Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes
    CIRCULATION
    
    N.S. Kleiman et al., "Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes", CIRCULATION, 101(7), 2000, pp. 751-757
88. Mark, DB; Harrington, RA; Lincoff, AM; Califf, RM; Nelson, CL; Tsiatis, AA; Buell, H; Mahaffey, KW; Davidson-Ray, L; Topol, EJ
    Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes
    CIRCULATION
    
    D.B. Mark et al., "Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes", CIRCULATION, 101(4), 2000, pp. 366-371
89. Newby, KH; Thompson, T; Stebbins, A; Califf, RM; Topol, EJ; Natale, A
    Sustained ventricular arrhythmias in patients receiving thrombolytic therapy - Response
    CIRCULATION
    
    K.H. Newby et al., "Sustained ventricular arrhythmias in patients receiving thrombolytic therapy - Response", CIRCULATION, 101(25), 2000, pp. E237-E238
90. Topol, EJ; Ohman, EM; Barnathan, E; Califf, RM; Lee, KL; Lincoff, AM; Ohman, EM; Scherer, J; Scott, R; Sketch, MH; Topol, EJ; Weisman, HF; Cantor, W; Evans, B; Harris, J; Kirby, J; Miller, J; Minshall, D; Oliverio, RM; Stebbins, AL; Webb, L; Wittlief, J; Topol, EJ; Lincoff, AM; Moliterno, DJ; Ivanc, T; Barnathan, E; Damaraju, L; Hadley, K; Kukulewicz, L; Scherer, J; Scott, R; Schwarz, R; Waller, M; Weisman, H; Lincoff, AM; Bachinsky, WB; Bell, C; Butler, JF; David, SW; Gibbs, K; Sakhaii, M; Hanovich, G; Herrmann, H; Hillegass, W; Kereiakes, DJ; Kiernan, J; McGrew, FA; Miklin, JS; Miller, L; Sketch, MH; Riba, A; Schreiber, TL; Smalling, RW; Talley, JD; Worley, S; Bates, ER; Hearne, S; Morris, DC; Priest, MF; Pelikan, P; Seals, AA; Smith, JE; Bach, RG; Laufer, N; Phillips, PS; McClure, R; Navetta, FI; Bhoopalam, V; Aylward, PE; Ardissino, D; Betriu, A; della Misericordi, OSM; Morocutti, G; Muller, DWM; Grinfeld, L; Cagide, A; Bode, C; Forycki, F; Lefkovits, J; Steg, G; Macaya, C; Schultheiss, HP; Eberli, F
    Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
    CIRCULATION
    
    E.J. Topol et al., "Trial of abciximab with and without low-dose reteplase for acute myocardial infarction", CIRCULATION, 101(24), 2000, pp. 2788-2794
91. Brooks, MM; Jones, RH; Bach, RG; Chaitman, BR; Kern, MJ; Orszulak, TA; Follmann, D; Sopko, G; Blackstone, EH; Califf, RM
    Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry
    CIRCULATION
    
    M.M. Brooks et al., "Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry", CIRCULATION, 101(23), 2000, pp. 2682-2689
92. Boersma, E; Pieper, KS; Steyerberg, EW; Wilcox, RG; Chang, WC; Lee, KL; Akkerhuis, KM; Harrington, RA; Deckers, JW; Armstrong, PW; Lincoff, AM; Califf, RM; Topol, EJ; Simoons, ML
    Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients
    CIRCULATION
    
    E. Boersma et al., "Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients", CIRCULATION, 101(22), 2000, pp. 2557-2567
93. Califf, RM; Pieper, KS; Lee, KL; Van de Werf, F; Simes, RJ; Armstrong, PW; Topol, EJ
    Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial
    CIRCULATION
    
    R.M. Califf et al., "Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial", CIRCULATION, 101(19), 2000, pp. 2231-2238
94. Crenshaw, BS; Granger, CB; Birnbaum, Y; Pieper, KS; Morris, DC; Kleiman, NS; Vahanian, A; Califf, RM; Topol, EJ
    Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction
    CIRCULATION
    
    B.S. Crenshaw et al., "Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction", CIRCULATION, 101(1), 2000, pp. 27-32
95. Lincoff, AM; LeNarz, LA; Despotis, GJ; Smith, PK; Booth, JE; Raymond, RE; Sapp, SK; Cabot, CF; Tcheng, JE; Califf, RM; Effron, MB; Topol, EJ
    Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials
    ANNALS OF THORACIC SURGERY
    
    A.M. Lincoff et al., "Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials", ANN THORAC, 70(2), 2000, pp. 516-526
96. Auerbach, AD; Hamel, MB; Davis, RB; Connors, AF; Regueiro, C; Desbiens, N; Goldman, L; Califf, RM; Dawson, NV; Wenger, N; Vidaillet, H; Phillips, RS
    Resource use and survival of patients hospitalized with congestive heart failure: Differences in care by specialty of the attending physician
    ANNALS OF INTERNAL MEDICINE
    
    A.D. Auerbach et al., "Resource use and survival of patients hospitalized with congestive heart failure: Differences in care by specialty of the attending physician", ANN INT MED, 132(3), 2000, pp. 191-200
97. Shah, MR; Granger, CB; Bart, BA; McMurray, JJV; Petrie, MC; Michelson, EL; Tudor, CE; Swedberg, K; Stevenson, LW; Califf, RM; Pfeffer, MA
    Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: The Study of Patients Intolerantof Converting Enzyme Inhibitors Registry
    AMERICAN JOURNAL OF MEDICINE
    
    M.R. Shah et al., "Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: The Study of Patients Intolerantof Converting Enzyme Inhibitors Registry", AM J MED, 109(6), 2000, pp. 489-492
98. Braunwald, E; Califf, RM; Cannon, CP; Fox, KAA; Fuster, V; Gibler, WB; Harrington, RA; King, SB; Kleiman, NS; Theroux, P; Topol, EJ; Van de Werf, F; White, HD; Willerson, JT
    Redefining medical treatment in the management of unstable angina
    AMERICAN JOURNAL OF MEDICINE
    
    E. Braunwald et al., "Redefining medical treatment in the management of unstable angina", AM J MED, 108(1), 2000, pp. 41-53
99. Birnbaum, Y; Wagner, GS; Gates, KB; Thompson, TD; Barbash, GI; Siegel, RJ; Granger, CB; Fishbein, MC; Crenshaw, BS; Califf, RM
    Clinical and electrocardiographic variables associated with increased riskof ventricular septal defect in acute anterior myocardial infarction
    AMERICAN JOURNAL OF CARDIOLOGY
    
    Y. Birnbaum et al., "Clinical and electrocardiographic variables associated with increased riskof ventricular septal defect in acute anterior myocardial infarction", AM J CARD, 86(8), 2000, pp. 830-834
100. O'Connor, CM; Gattis, WA; Shaw, L; Cuffe, MS; Califf, RM
     Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function
     AMERICAN JOURNAL OF CARDIOLOGY
     
     C.M. O'Connor et al., "Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function", AM J CARD, 86(8), 2000, pp. 863-867